We invite you to read the latest news about The France Foundation and our collaborators as well as review our latest press releases.

 

Update

OLD LYME, CT — JANUARY 27, 2017 — The France Foundation, a leading medical education company, announced that it has received the 2017 Award for Outstanding Live Continuing Education (CE) Activity from the Alliance for Continuing Education in the Health Professions (ACEhp) for a program on Improving MDS Outcomes from Diagnosis to Treatment: A Multidisciplinary Approach, in collaboration with the American Society for Clinical Pathology (ASCP) and the American Society of Hematology (ASH). This initiative was supported by an independent educational grant from Celgene Corporation.


Press Release

OLD LYME, CT — JANUARY 23, 2017 — The France Foundation, a leading medical education company, announced they have received their second accreditation with commendation as a provider of continuing medical education by the Accreditation Council for Continuing Medical Education (ACCME). ACCME accreditation with commendation is the highest level of accreditation and places The France Foundation amongst the top 38% of providers of continuing medical education in the United States, which includes some of the nation’s most prestigious medical schools, national medical societies, and leading hospitals. ACCME-accredited providers certify educational activities for the American Medical Association’s Physician’s Recognition Award (“AMA PRA”). The AMA PRA is utilized by state licensing boards and boards of medical specialties to re-license physicians and re-certify them in their areas of specialty.


Update

OLD LYME, CT — NOVEMBER 15, 2016 — Clinicians are often unaware of their own educational gaps and can often demonstrate high levels of confidence in procedures that they are performing suboptimally.1 So, how can we engage learners if they are unaware of their own educational gaps? Over the course of the last 6 months, The France Foundation collaborated with The Calibre Institute for Quality Medical Education to answer this question and deliver impactful biosimilars education that best addresses the needs of clinicians. Our goal was to increase clinician awareness, knowledge, and confidence regarding the role of biosimilars in clinical care, which have the potential for a notably positive impact on patient access to biologic therapy, as well as cost of care.


Update

OLD LYME, CT — JUNE 20, 2016 — Combining traditional and innovative educational formats to drive improvements in the treatment of patients with diabetes. Presented as a poster at the AAPA Annual Conference and recognized at the CBI Medical Education & Research Grants Breakthrough Summit.


Update

OLD LYME, CT — MARCH 15, 2016 — Key members of the pulmonary fibrosis (PF) community and Broadway’s finest united for a unique evening of exceptional entertainment during the sixth annual Broadway Belts for PFF! Raising $180,000 in one evening, proceeds are used to battle PF, a devastating and relentlessly progressive disease involving scarring of the lungs.


Update

OLD LYME, CT — MARCH 15, 2016 — Using Gamification and Implementation Science to Promote Knowledge Retention and Behavior Modification
Along with Lois Colburn of the University of Nebraska Medical Center, The France Foundation will be talking about one of their innovative and successful programs on adult immunizations. This novel education utilized gamification and implementation science to engage learners in an interactive learner session that provided interactivity and practical tools for behavior modification. Based on the theories of facilitated learning, clinicians were active participants in identifying issues as well and developing solutions.


Update

OLD LYME, CT — MARCH 15, 2016 — That is the question posed by the board of the World Conference on Interventional Oncology (WCIO) and together in partnership with The France Foundation set out to create a solution for this need. Interventional oncology (IO) represents one of the more exciting and evolving fields in medicine and has been growing rapidly as more minimally invasive approaches emerge in cancer treatment.1-4 Clinicians working in IO must be able to understand and undertake IO approaches in the context of, and sometimes in combination with, standard cancer treatments. A recent study of chemoembolization practices primarily within the United States showed a lack of consensus on treatment endpoints and embolization technique.5-6 Why? Such comprehensive education and training has not existed in current Interventional Radiology training programs. Until now. We have set out to make a change and deliver a centralized, comprehensive, expert-informed certified educational resource to guide practitioners.


Update

OLD LYME, CT — JANUARY 8, 2016 — When PILOT was launched in 2004, like most in the education industry, we were thinking about knowledge. We were working hard on getting the word out. We were trying to improve awareness and activate the multidisciplinary team. With no approved therapies, keeping it top of mind was all we could do. We could talk about diagnosis and potential ways to manage IPF, but outside of symptomatic care and lung transplantation we really didn’t have much to offer in terms of patient care (performance).


Update

OLD LYME, CT — JANUARY 8, 2016 — In 2015, to advance the knowledge and adoption of state-of-the-art MS care, the Advances in Multiple Sclerosis (AIMS) curriculum zeroed in on special considerations specifically related to women with multiple sclerosis (MS) and practical rehabilitation topics and techniques. According to survey data obtained through 6 AIMS activities, due to the continued prevalence of MS and the ongoing advances in the diagnosis and management of the disease, neurologists and other health care providers continue to recognize the need to “keep abreast of new developments on emerging therapies for MS.”


Update

OLD LYME, CT — SEPTEMBER 25, 2015 — Medical education often neglects the most important voice, ignoring the reason why we do what we do. How is it we can develop education that combines the hard facts of science and the complex art of treatment selection, but completely ignores the patient perspective? Medical education needs to adopt a clinical approach that validates the patient’s perspective and experiences, and incorporates it into the design as well as evaluation of the education.


News

OLD LYME, CT — SEPTEMBER 25, 2015 — Whether you call it personalized medicine, individualized medicine or precision medicine, the customization of health care with decisions and treatments tailored to each individual patient is greatly influenced by both genetics and genomics. Currently, more than 100 drugs have label information regarding pharmacogenomic biomarkers (genomics), some measurable or identifiable segment of genetic information that can be used to direct the use of a drug. Additionally, genes also identify those at risk (genetics) for disease; these patients may benefit from preventative and preemptive care. With personalized medicine, molecular biomarkers can allow the physician to better predict how a patient will respond to a particular drug based on their test results. It is also possible to identify who needs and who does NOT need aggressive treatment.


News

OLD LYME, CT — JUNE 2, 2015 —The first biosimilar was approved in the US in March, and there are many more approvals anticipated. The introduction of biosimilars into the US market is expected to expand patient access to biologic therapies and reduce health care costs.


News

OLD LYME, CT — JUNE 2, 2015 — A poster presentation was awarded to the "GAIN (EnGAging an Interdisciplinary Team for NSCLC Diagnosis, Personalized Assessment & Treatment) Europe Collaborators", which included the American Society for Clinical Pathology (ASCP), American College of Chest Physicians (CHEST), and The France Foundation (TFF).


Press Release

OLD LYME, CT — MARCH 2, 2015 — The PILOT™ (Pulmonary Fibrosis Identification: Lessons for Optimizing Treatment) initiative, a cornerstone in IPF education for over a decade, is partnering with the Pulmonary Fibrosis Foundation to bring about state-of-the-art education focused on idiopathic pulmonary fibrosis (IPF). This unique collaboration will bring education to the local level by working in conjunction with major idiopathic lung disease (ILD) centers across the country. In a rare opportunity, patients will have the ability to interact with clinicians within these ILD centers as well as clinicians from the community setting.


Press Release

HACKENSACK, NJ — NOVEMBER 20, 2014 — The Consortium of Multiple Sclerosis Centers (CMSC), The France Foundation, and the Nurse Practitioner Alternatives (NPA) are pleased to announce that “Confronting Current Challenges in Multiple Sclerosis Treatment: A Unique Individualized Learning Plan,” has been selected as the winner for the 2015 Outstanding CE Enduring Material by the Alliance for Continuing Education in the Health Professions.


Press Release

OLD LYME, CT — FEBRUARY 20, 2014 — The PILOT™ (Pulmonary Fibrosis Identification: Lessons for Optimizing Treatment) initiative, a cornerstone in IPF education for almost a decade, will be expanding its educational offerings in 2014 with educational grant support from Boehringer Ingelheim and InterMune. “I am honored to be a part of this very important initiative in providing education about IPF, a disease that is often difficult to diagnose and for which effective treatments are currently lacking,” commented Dr. Steven Nathan, Medical Director of the Advanced Lung Disease and Lung Transplant Program at Inova Fairfax Hospital. “This is a particularly exciting time in the field since the results from a number of pivotal treatment trials are due to be released in the near future.” Dr. Nathan is also the Chair of the PILOT 2014 initiative.


Press Release

OLD LYME, CT — JANUARY 24, 2014 — The France Foundation, the American College of Chest Physicians and the American Society for Clinical Pathology (ASCP) are working together on an initiative to educate respirologists/pulmonologists, pathologists, and oncologists in Europe on the optimal diagnosis and treatment of non-small cell lung cancer (NSCLC). This continuing medical education initiative titled GAIN Europe (EnGAging an Interdisciplinary Team for NSCLC Diagnosis, Personalized Assessment, and Treatment) will be conducted across Europe in 2014.


Press Release

OLD LYME, CT — JANUARY 24, 2014 — During the 2014 Alliance for Continuing Education in the Health Professions Annual Conference, the American Academy of Dermatology and The France Foundation will receive the 2014 Outstanding Innovation in CPD for the CE/CPD Professional award. This award is in recognition of the innovative design and impact of “The ABCs of Accredited CME” initiative. “ABCs of Accredited CME” is an online series of educational modules designed for continuing education (CE) planners and faculty. Given in honor of Rafael Sanchez, MD, dedicated physician, educator, and CME leader, this award recognizes outstanding innovation in continuing professional development.


Press Release

OLD LYME, CT — JANUARY 24, 2014 — The France Foundation, along with the University of Nebraska Medical Center (UNMC), Federation of State Medical Boards (FSMB), FSMB Foundation, and CECity have been awarded a grant to educate health care providers on the Risk Evaluation and Mitigation Strategies (REMS) for extended-release and long-acting (ER/LA) opioid analgesics set forth by the Food and Drug Administration (FDA). This program will be dedicated to offering both live and online education meeting criteria set forth by the FDA for the ER/LA opioid REMS. The grant was awarded by the REMS Program Companies (RPC), a consortium of opioid manufacturers responsible to the FDA.


Press Release

OLD LYME, CT — OCTOBER 30, 2013 — The France Foundation and the American Urogynecologic Society (AUGS), working with urogynecologist Peter L. Rosenblatt, MD, have developed BladderTrakHer. The new app, developed with support from Astellas Pharma Inc., was designed to assist female patients with overactive bladder (OAB). The app is helping female patients and their clinicians evaluate and communicate about OAB symptoms. BladderTrakHer has had more than 875 downloads by patients internationally since its release earlier this year.


Press Release

OLD LYME, CT — OCTOBER 30, 2013 — For the second year, The France Foundation has worked  closely with the American Society for Microbiology (ASM) to jointly sponsor the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) for physician, pharmacist, and laboratory clinician continuing education credits. This year’s successful ICAAC meeting, the premier meeting on antimicrobial agents and infectious diseases, was held from September 10-13 in Denver, Colorado, and included 255 sessions representing faculty researchers from around the world.


Press Release

OLD LYME, CT — OCTOBER 30, 2013 — The France Foundation and the American Society for Clinical Pathology (ASCP) have launched an educational program for pathologists on myelodysplastic syndrome (MDS), supported by an educational grant from Celgene. MDS is a rare blood disorder that is difficult to diagnose, frequently misdiagnosed, and transforms into acute myelogenous leukemia in about one-third of patients.


Press Release

SAN FRANCISCO, CA — JANUARY 31, 2013 — During the 2013 Alliance for Continuing Education in the Health Professions Annual Conference, The France Foundation and the American Academy of Dermatology received the 2013 Medical Specialty Societies Member Section Great Idea Award for their work developing The ABCs of Accredited CME. This initiative consists of an online series of educational modules designed for continuing medical education (CME) planners and faculty. The Great Idea Awards are presented by the Alliance in recognition for an outstanding contribution to the field of continuing education in a designated member section.


Press Release

CHICAGO, IL  July 13, 2011 — SmithBucklin Corporation, the world’s largest association management company, announced today that it acquired The France Foundation, Inc., a recognized leader in accredited continuing medical education (CME) in the United States. The announcement was made by Henry S. Givray, President and CEO of SmithBucklin, and Kelly Angelini, founder and owner of The France Foundation.


Update

OLD LYME, CT  DECEMBER 16, 2010 — Theodore Bruno, MD, Chief Medical Officer and Stacy Miller, Executive Vice President and Chief Operations Officer of The France Foundation, are pleased to announce that The France Foundation, based in Old Lyme, CT has received its accreditation with commendation as a provider of continuing medical education by the Accreditation Council for Continuing Medical Education (ACCME). ACCME accreditation with commendation, or Level 3, means that The France Foundation is among the top 8% of providers of continuing medical education (CME) in the United States. This accolade places The France Foundation in the top tier of all CME providers, including some of the nation’s most prestigious medical schools and professional medical societies. ACCME-accredited providers certify educational activities for AMA PRA (American Medical Association’s Physician’s Recognition Award) Category 1 Credit™. The AMA PRA is utilized by state licensing boards and boards of medical specialties to re-license physicians and re-certify them in their areas of specialty. Earlier this year, The France Foundation also received the highest level of accreditation for its pharmacist education programs as an accredited provider of the Accreditation Council for Pharmacy Education (ACPE).

Updates

  • The France Foundation, ASCP, and ASH Awarded 2017 Outstanding Live Continuing Education Activity by the Alliance for Continuing Education in the Health Professions

    Read More ...

  • The France Foundation Receives ACCME Accreditation with Commendation as a Provider of Continuing Medical Education

    Read More ...

Upcoming Events

No events

Featured Online Activities